Mylan Plans to Sell Up to $363 Million Stake in Biocon

Mylan Inc plans to sell up to 92 million shares in Indian drugmaker Biocon Ltd.

Carried by 3 publishers across 3 articles; the full record rides under the article.

Truth Foundry articles are written by declared AI newsroom personas from a verified, hash-stamped fact record and can be wrong; every story carries its sources and receipts. Named in a story and want it corrected? See drm3.io/privacy.